Finance

Lists
524572:BOM
Pharmaids Pharmaceuticals Ltd
30,59 ₹
+0,46%
(+0,14) 1D
16 қаз., 15:30:00 GMT+5:30  ·   INR
All symbols
SymbolPriceChange% Change
Generating top insights for 524572...
Open
30,35 ₹
High
32,50 ₹
Low
29,80 ₹
Mkt. cap
1,06 млрд
Avg. vol.
3,45 мың
Volume
3,76 мың
52-wk high
53,90 ₹
52-wk low
25,60 ₹
EPS
-1,29 ₹
Shares outstanding
3,41 млн
No. of employees
127
Open
30,35 ₹
High
32,50 ₹
Low
29,80 ₹
Mkt. cap
1,06 млрд
Avg. vol.
3,45 мың
Volume
3,76 мың
52-wk high
53,90 ₹
52-wk low
25,60 ₹
EPS
-1,29 ₹
Shares outstanding
3,41 млн
No. of employees
127
News stories
From web sources and news partners
About Pharmaids Pharmaceuticals Ltd
CEO-
Employees127
Founded1989
Headquarters-
SectorPharmaceutical industry
Websitepharmaids.com
Last report
2026 ж. 12 там.
Fiscal period
Q1 2027
- / -
Revenue / Est. (INR)
41,21 млн / -
Fiscal Q1 2027 earnings call
Waiting for the earnings call
At a glance
Insights from the latest news and reports
Previous reportsAll values in INR
Loading Previous Earnings...
Revenue
Net income
All values in INR
2025 ж. қыр.
2025 ж. жел.
2026 ж. нау.
2026 ж. мау.
Revenue
86,05 млн
54,30 млн
71,84 млн
41,21 млн
Cost of goods sold
75,50 млн
23,48 млн
45,15 млн
16,17 млн
Cost of revenue
75,50 млн
23,48 млн
45,15 млн
16,17 млн
Research and development expenses
-
-
-
-
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
31,81 млн
32,83 млн
76,78 млн
24,66 млн
Operating expense
68,44 млн
60,62 млн
34,80 млн
37,34 млн
Total operating expenses
143,95 млн
84,10 млн
79,94 млн
53,52 млн
Operating income
-57,90 млн
-29,80 млн
-8,11 млн
-12,30 млн
Other non operating income
2,22 млн
760,00 м.
-2,73 млн
483,00 м.
EBT including unusual items
-36,57 млн
-40,22 млн
-14,56 млн
24,14 млн
EBT excluding unusual items
-66,45 млн
-36,22 млн
-12,62 млн
-17,86 млн
Income tax expense
-11,29 млн
-13,76 млн
-3,71 млн
5,43 млн
Effective tax rate
30,87%
34,20%
25,48%
22,49%
Other operating expenses
31,96 млн
23,04 млн
-46,75 млн
7,83 млн
Net income
-24,80 млн
-24,79 млн
-18,09 млн
22,05 млн
Net profit margin
-28,83%
-45,65%
-25,18%
53,51%
Earnings per share
-
-
-
-
Interest and investment income
-
-
1,54 млн
-
Interest expense
-10,77 млн
-7,18 млн
-4,36 млн
-6,04 млн
Net interest expenses
-10,77 млн
-7,18 млн
-2,82 млн
-6,04 млн
Depreciation and amortization charges
4,68 млн
4,76 млн
4,77 млн
4,86 млн
EBITDA
-52,53 млн
-25,07 млн
-4,50 млн
-7,23 млн
Gain or loss from assets sale
-
-
-
-
AI content may include mistakes. Learn more
HelpSend feedbackPrivacyTermsDisclaimer
Google қолданбалары